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Abstract Synaptotagmin I, the calcium sensor for neurotrans-
mission, is palmitoylated. We have identi¢ed the palmitoylation
sites as ¢ve cysteine residues located between the transmem-
brane and cytoplasmic regions. In contrast to wild-type synap-
totagmin, the non-acylated mutant is not converted to the endo-
glycosidase-H-resistant form after expression in CV-1 cells.
This indicates a block in transport through the Golgi complex.
However, when expressed in PC-12 and RBL cells non-acylated
synaptotagmin is targeted to the plasma membrane and to se-
cretory granules. No signi¢cant cleavage of [3H]palmitate from
synaptotagmin was observed in pulse-chase experiments. This
indicates that the majority of fatty acids are structural rather
than dynamic components.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Synaptotagmin I, an abundant protein of synaptic vesicles,
is the putative Ca2þ sensor for neurotransmission. It consists
of a small luminal N-terminal segment, a single transmem-
brane region (TMR), and a large cytoplasmic domain, which
contains the two calcium-binding C2 domains. A cysteine-rich
region and a highly charged domain connect the TMR to the
C2 domains [1^3].
Intracellular processing and protein modi¢cations of synap-
totagmin are not well understood. The TMR including neigh-
bouring amino acids is required for targeting to the endoplas-
mic reticulum and translocation of the N-terminal domain [4].
The luminal domain contains a single site for N-glycosylation
and two sites for O-glycosylation [5,6]. The latter are utilised
only when the neuronal synaptosomal protein receptor
(SNARE) protein vesicle-associated membrane protein 2 is
expressed in the same cell. Two oligomerisation steps, Ca2þ-
dependent and Ca2þ-independent, have also been described
[3].
A further modi¢cation of synaptotagmin is palmitoylation
of cysteine residues, which are probably located in the cys-
teine-rich region [7,8]. Interestingly, mutagenic exchange of
these cysteine residues blocked dimerisation of synaptotag-
min, thus linking fatty acylation to Ca2þ-independent oligo-
merisation [9,10]. This replacement reduced the molecular
weight of the mutated protein [9], but it was not directly
demonstrated that cysteine mutants are not acylated. Further-
more, the role of palmitoylation for processing and intracel-
lular transport of synaptotagmin has not yet been analysed.
2. Materials and methods
2.1. Recombinant DNA methods
Construction of synaptotagmin mutants was done with overlap ex-
tension polymerase chain reaction as described [11]. The following
primers were used: pTM sense GGG AAT TCC CCG GGG AGC
TCA G; pTM antisense TTA GGC CTC TCG AGC TCG ACC CT;
Tag C1 sense TCC TGC TTT TGT GTC TGT AAG AAA TGT
TTG TTC AAG AAA TG; Tag C1 antisense CTT ACA GAC
ACA AAA GCA GGA GGT TAC GAC TAA AAG GAC; Tag
C1/2 sense TCC TCC TTT TGT GTC TGT AAG AAA TGT TTG
TTC AAG AAA TG; Tag C1/2 antisense CTT ACA GAC ACA
AAA GGA GGA GGT TAC GAC TAA AAG GAC; Tag C3/4 sense
TCT GTC TCT AAG AAA TGT TTG TTC AAA AAG AAA AAC
AAG AAG AAG GGG; Tag C3/4 antisense CAT TTC TTA GAG
ACA GAA AAG CAG CAG GTT ACG AC; Tag C3-5 sense TCT
GTC TCT AAG AAA TCT TTG TTC AAA AAG AAA AAC AAG
AAG AAG GGG; Tag C3-5 antisense GAT TTC TTA GAG ACA
GAA AAG GAG GAG GTT ACG AC; Tag C5 sense TGT GTC
TGT AAG AAA TCT TTG TTC AAA AAG AAA AAC AAG AAG
AAG GGG; Tag C5 antisense GAT TTC TTA CAG ACA CAA
AAG CAG CAG GTT ACG AC; Tag C1/2/5 sense TGT CTG
TGT AAG AAA TCT TTG TTC AAA AAG AAA AAC AAG
AAG AAG GGG; Tag C1/2/5 antisense GAT TTC TTA CAG
ACA CAA AAC CAC CAG GTT ACG AC.
For expression of tagmin in PC-12 cells the plasmid pcDNA3.1-
myc-his(+) was used (Invitrogen). The tagmin gene was ampli¢ed
from pTM1 with an N-terminal primer equipped with an EcoRI site
and a C-terminal primer (without the stop codon) and an XbaI site.
These enzymes were used to clone the tagmin gene (wt and mutant
1-5) into pcDNA3.1-myc-his resulting in full-length protein with a
myc tag at the C-terminus. For expression of tagmin in RBL-2H3
cells, tagmin (wt and mutant 1-5) was excised from pTM1 with EcoRI
and BamHI and subcloned into the corresponding sites of the plasmid
pEGFP-C1 (Clontech). This results in full-length proteins fused at the
N-terminus to the green £uorescent protein (GFP).
2.2. Expression, metabolic labelling and immunoprecipitation
Expression, metabolic labelling and immunoprecipitation of tagmin
with the M49 monoclonal antibody were done as described [8]. The
immunoprecipitated protein was digested with 1 Wl endoglycosidase-H
(Endo-H) as described by the manufacturer (NEB).
2.3. Indirect immuno£uorescence
PC-12 cells (5U104) were seeded into 24-well plates covered with
poly-D-lysine and cultured in Dulbecco’s medium supplemented with
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10% foetal calf serum, 5% horse serum and 50 ng/ml nerve growth
factor (NGF) for 3 days. Cells were then transfected for 4 h or over-
night with lipofectin (10 Wl) and 3 Wg pcDNA3.1-myc-his(+)-synapto-
tagmin plasmid. Cells were then removed from the plates, pelleted and
seeded onto coverslips treated with poly-D-lysine, and were further
cultured for 2 days in the presence of NGF. Cells were then ¢xed
for 15 min with paraformaldehyde (3%) and permeabilised with Tri-
ton X-100 (0.1%). Synaptotagmin was stained with anti-myc mono-
clonal antibody 9E10 (1:200) and FITC-conjugated anti-mouse IgGs
(1:50, Sigma). Coverslips were mounted in 90% glycerol and visual-
ised with a confocal microscope (Leica TCS SP2 system with Leica
DM IRBE). RBL-2H3 cells, a cell line usually used as a model for
mast cells, were seeded on coverslips and cultured in Dulbecco’s me-
dium supplemented with 10% foetal calf serum. Cells (80% con£uent)
were transfected for 4 h with 2 Wg pEGFC1-synaptotagmin plasmids
and lipofectin (10 Wl). Two days later coverslips were washed in phos-
phate-bu¡ered saline and distilled water and mounted in 90% glycerol.
Results were visualised with a Zeiss Axioscope microscope and re-
corded with a Nikon Coolpix 995 camera.
3. Results and discussion
3.1. Five cysteines are involved in palmitoylation of
synaptotagmin I
Cysteine residues located between the transmembrane and
cytoplasmic regions have been identi¢ed as palmitoylation
sites in numerous proteins [12]. With one exception (tagmin
XII), all synaptotagmin isoforms and also their orthologues
from lower eukaryotes have at least one cysteine in this region
[9]. In synaptotagmin I ¢ve cysteines are present. Assuming
that the ¢rst positively charged amino acid (lysine) marks the
boundary, one cysteine is located in the cytoplasmic tail and
four cysteines are in the transmembrane region. To prove that
the cysteines are indeed the palmitoylation sites, one, two or
three cysteines were replaced by serine residues. In one mutant
(M1-5) all ¢ve cysteines were replaced simultaneously (see Fig.
1A). Wild-type and mutant tagmins were expressed with the
T7 polymerase vaccinia virus system in non-neuronal CV-1
cells [11]. Labelling with [35S]methionine and immunoprecipi-
tation showed that wild-type and mutant forms of tagmin are
Fig. 1. Identi¢cation of palmitoylation sites in synaptotagmin I. A: Site-speci¢c mutagenesis of cysteine residues. Amino acids at the boundary
between the cytoplasmic tail and the TMR of synaptotagmin I (cloned from rat) are shown. Cysteine residues are in bold. One, two, three or
all ¢ve cysteine residues were replaced by serines (bold and italics). B,C: Synaptotagmin I and the cysteine mutants were expressed with the
vaccinia T7 polymerase system in CV-1 cells and labelled for 1 h with [35S]methionine (B) or [3H]palmitate (C). Tagmin was then immunopreci-
pitated from cellular extracts and subjected to SDS^PAGE and £uorography. The sensitivity or resistance of protein bands against Endo-H di-
gestion (analysed in Fig. 2) is also indicated. unglyco=unglycosylated protein. Bands with a higher molecular weight, which might represent
dimers [9], were not detected under our experimental conditions. D: Densitometric quanti¢cation of bands shown in B and C and from four
identical experiments. The mean of relative palmitoylation (wild-type protein= 100%) including the variance is shown.
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expressed at similar levels (Fig. 1B). Labelling with
[3H]palmitate revealed that only the mutant with all ¢ve cys-
teines replaced lacked fatty acids completely. The other cys-
teine mutants showed [3H]palmitoylation, albeit at reduced
levels (Fig. 1C). The acylation e⁄ciency of the tagmin mu-
tants was quanti¢ed by densitometry of 35S- and 3H-labelled
bands. The most signi¢cant result was that exchange of a
single cysteine decreased palmitoylation more than half com-
pared to the wild-type protein (Fig. 1D). Replacing two or
three cysteines leads to a further reduction of palmitoylation.
The drastic reduction in palmitoylation after replacement of a
single cysteine is surprising. One likely explanation could be
that it decreased the transport of tagmin to the intracellular
site of palmitoylation (see below). Nevertheless, all ¢ve cys-
teine residues are, directly or indirectly, involved in the palmi-
toylation reaction. However, it cannot be inferred from these
data that each cysteine is palmitoylated in each synaptotag-
min molecule.
3.2. Processing of wild-type synaptotagmin in CV-1 cells
Synaptotagmin occurs in multiple bands in the SDS gel
(Fig. 1B). One obvious explanation would be that the bands
represent di¡erent processing steps of the single N-linked car-
bohydrate side chain. To con¢rm this assumption we con-
ducted a series of pulse-chase experiments with [35S]methio-
nine and digested an aliquot of the immunoprecipitated pro-
tein with Endo-H, a glycosidase which cleaves N-linked car-
bohydrates of the high-mannose type (Fig. 2A). Freshly syn-
thesised tagmin (10 min labelling) occurs as three bands
during sodium dodecyl sulfate^polyacrylamide gel electro-
phoresis (SDS^PAGE) analysis. The upper two bands are
sensitive to Endo-H and therefore must represent N-glycosy-
lated molecules with sugars of the mannose-rich type [13]. The
fastest-migrating band has the same size as the Endo-H-di-
gested product and is therefore not glycosylated. After 30 min
of chase a fuzzy band with the highest molecular weight ap-
pears, which is resistant to digestion with Endo-H thus rep-
resenting the protein species containing complex carbohy-
drates.
Next we asked whether the two Endo-H-sensitive bands
occur independently of each other or if one band is the pre-
cursor to the other. Short pulse-labelling (2 min) showed only
Fig. 2. Processing of non-acylated tagmin is impaired in CV-1 cells. A: Acylated tagmin is processed to an Endo-H-resistant form. Wild-type
tagmin was expressed in CV-1 cells, labelled for 10 min with [35S]methionine and then chased for 0, 30, 60 or 120 min. Tagmin was immuno-
precipitated and equal aliquots were digested with Endo-H (+) or were mock-digested (3) prior to SDS^PAGE and £uorography. The position
of molecular weight markers is shown on the right side of the £uorogram. B: Acylated (wt) and non-acylated (1-5) synaptotagmin were labelled
for 2 min with [35S]methionine. Tagmin was immunoprecipitated and subjected to SDS^PAGE and £uorography. C: Wild-type tagmin was ex-
pressed in CV-1 cells, labelled for 120 min with [3H]palmitate, immunoprecipitated and equal aliquots were digested with Endo-H (+H) or
were mock-digested (3H). D: Non-acylated tagmin does not acquire Endo-H resistance. Tagmin mutant 1-5 was expressed in CV-1 cells, la-
belled for 1 h with [35S]methionine and an aliquot of the immunoprecipitated protein was digested with Endo-H (+H) or was mock-digested
(3H). E: Tagmin mutant 1-5 was labelled for 15 min with [35S]methionine and then chased for 0, 15, 30, 45, 60 or 120 min prior to immuno-
precipitation. F: Acylated (wt) and non-acylated (1-5) tagmin were expressed in CV-1 cells, labelled for 16 h with [35S]methionine and subjected
to immunoprecipitation, SDS^PAGE and £uorography. C: non-transfected CV-1 cells. G: Acylated (wt) and non-acylated (1-5) and the other
cysteine mutants (see Fig. 1A) of tagmin were labelled for 2 h with [35S]methionine. The proteins were immunoprecipitated and subjected to
SDS^PAGE and £uorography. The £uorogram is overexposed to show that the upper, fully processed band is detectable for all mutants except
the completely non-acylated mutant 1-5.
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two bands, which represent the unglycosylated and the ¢rst
Endo-H-sensitive form of tagmin (Fig. 2B). Likewise, inspec-
tion of the pulse-chase experiment (Fig. 2A) showed that the
faster-migrating form is converted into the slower-migrating
form after 30 min of chase. Thus, processing of synaptotag-
min expressed in CV-1 cells occurs in three steps: core glyco-
sylation, rapid conversion to a slower-migrating, but still
Endo-H-sensitive form, and ¢nally slow processing to the
Endo-H-resistant form. The reason for the di¡erence in the
molecular weight of the two Endo-H-sensitive forms is not
known. The usual processing of carbohydrates before they
acquire Endo-H resistance only involves cleavage of sugars
and should therefore not result in an increase in molecular
weight [13]. Palmitoylation is also not responsible for the shift
in the molecular weight because (i) wild-type and non-acylated
tagmin have the same molecular weight (Fig. 1A), (ii) the
slower-migrating form is also labelled with [3H]palmitate
(Fig. 1C) and (iii) the Endo-H-sensitive band with the higher
molecular weight is also detectable with non-acylated synap-
totagmin (Fig. 2C, discussed below). Perhaps another, uniden-
ti¢ed protein modi¢cation is responsible for the increase in
molecular weight.
Which of the described forms of synaptotagmin are palmi-
toylated in CV-1 cells? Cells expressing wild-type synaptotag-
min were labelled for 120 min with [3H]palmitate and the
immunoprecipitated protein was treated with Endo-H prior
to SDS^PAGE and £uorography. Inspection of the
[3H]palmitoylated protein showed three bands (Fig. 2C, see
also Fig. 1C). The upper band is resistant to Endo-H, the
lower two bands are sensitive to Endo-H. The unglycosylated
form of tagmin is not palmitoylated. Thus, it is likely that
palmitoylation occurs on the ¢rst, Endo-H-sensitive band,
which is then processed to the later forms during the
[3H]palmitate labelling period. This is consistent with other
studies showing that palmitoylation of transmembrane pro-
teins occurs before acquisition of Endo-H resistance [14].
3.3. Processing of non-acylated synaptotagmin in CV-1 cells
Resistance of carbohydrate chains to Endo-H is due to the
action of N-acetylglucosamine transferase, an enzyme located
Fig. 3. Targeting of acylated and non-acylated tagmin in PC-12 and RBL cells. A,B: Di¡erentiated PC-12 cells were transfected with wild-type
(A) or non-acylated (mutant 1-5, B) tagmin^myc constructs and stained 2 days later with anti-myc 9E10 antibodies and FITC-conjugated anti-
mouse IgGs. Results were recorded with confocal microscopy. C^F: RBL-2H3 cells were transfected with wild-type (C,D) or non-acylated (mu-
tant 1-5, E,F) GFP^tagmin constructs. Two days later results were recorded with £uorescence microscopy.
Fig. 4. Fatty acids are stably attached to tagmin and SNAP-25 in PC-12 cells. A: PC-12 cells containing endogenous synaptotagmin and
SNAP-25 were labelled for 30 min with [3H]palmitate and then chased for 0 or 1 h. SNAP-25 and tagmin were immunoprecipitated and sub-
jected to SDS^PAGE and £uorography. B,C: PC-12 cells were labelled for 2 h and then chased for 0.5, 1, 2, 3 or 4 h. D: Protein synthesis in
PC-12 cells was blocked with cycloheximide (50 Wg/ml) and cells were labelled simultaneously or 10, 20, 40 or 60 min later with [3H]palmitate
for 30 min. Synaptotagmin was then immunoprecipitated and subjected to SDS^PAGE and £uorography. C=no addition of cycloheximide.
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in the medial Golgi apparatus [13]. Thus, palmitoylated syn-
aptotagmin expressed in CV-1 cells passes the medial Golgi
cisternae. This is consistent with other studies, where synap-
totagmin expressed in CHO cells was transported to the plas-
ma membrane [15].
Does the non-acylated mutant of tagmin follow the same
intracellular pathway of processing? Because in Fig. 1B acyl-
ated and non-acylated tagmin show di¡erent band patterns,
we conducted more detailed experiments. In contrast to the
wild-type protein, unpalmitoylated tagmin is present after 1 h
of labelling as only two bands, which represent the unglyco-
sylated and Endo-H-sensitive form of the protein (Fig. 2D).
In a pulse-chase experiment the second Endo-H-sensitive form
of the protein is clearly visible only after 2 h of chase (Fig.
2E). However, with this mutant a fuzzy, Endo-H-resistant
band fails to appear after 2 h of chase (Fig. 2E) and is only
barely detectable after 16 h of labelling (Fig. 2F). Thus, trans-
port of non-acylated synaptotagmin is impaired at a site prior
to the medial Golgi complex.
Is the replacement of a single cysteine residue, which is
accompanied by a drastic reduction in palmitoylation, su⁄-
cient to prevent processing of tagmin to the Endo-H-resistant
form? Labelling with [35S]methionine for 2 h showed the
upper, fully processed band for every cysteine mutant except
the completely non-acylated mutant 1-5 (Fig. 2G). Thus, only
when all ¢ve cysteines are exchanged the intracellular trans-
port of synaptotagmin is blocked.
Exchange of cysteine residues has a further e¡ect on pro-
cessing of synaptotagmin. It is apparent from Figs. 1B and 2B
that the band with the lowest molecular weight, which we
have identi¢ed as unglycosylated tagmin, is much more prom-
inent in the cysteine mutants. Unglycosylated synaptotagmin
most likely arises because the N-terminus of the protein is not
translocated into the lumen of the endoplasmic reticulum,
where core glycosylation occurs during translation. Palmitoy-
lation is a post-translational event. Thus, increased occurrence
of unglycosylated tagmin cannot be due to the loss of protein-
bound fatty acids, but rather to exchange of the cysteine res-
idues. Recently, it has been suggested that a helical hairpin is
formed between the transmembrane domain and a N-terminal
region that is required for e⁄cient translocation [16]. Thus,
exchange of cysteine residues in the transmembrane region
might in£uence formation (or subsequent disassembly) of
the helical hairpin and this might lead to ine⁄cient transloca-
tion of the molecule. In support of this, mutant 5 shows only
a very low amount of unglycosylated synaptotagmin, just like
the wild-type protein. This particular mutant is the only one
with an exchange of a cysteine not located in the TMR.
3.4. Targeting of wild-type and non-acylated synaptotagmin in
PC-12 and RBL cells
The results so far indicate that non-acylated synaptotagmin
is not properly processed in CV-1 cells. We therefore asked
whether we could detect di¡erences in intracellular targeting
between palmitoylated and non-acylated tagmin when the
proteins are expressed in PC-12 cells, a neurone-like cell
line. Because transfection of PC-12 cells is ine⁄cient and de-
tailed metabolic labelling studies are di⁄cult, we analysed
subcellular targeting by £uorescence microscopy. Wild-type
and non-acylated tagmin were equipped with a C-terminal
myc tag and were transfected into NGF-di¡erentiated PC-12
cells. Staining with myc antibodies and confocal laser micros-
copy clearly showed non-acylated tagmin at the plasma mem-
brane, both in the cell body and at the tip of the neurites (Fig.
3A,B).
Secretory vesicles are not clearly visible in our immuno£uo-
rescence pictures of PC-12 cells. To analyse whether acylated
and non-acylated tagmins are also transported to secretory
organelles, we fused both proteins at the N-terminus to the
GFP and transfected the constructs into RBL-2H3 cells, a
mast cell line with prominent secretory granules. Targeting
of synaptotagmin I to these organelles has already been dem-
onstrated by cell fractionation [20]. Fluorescence microscopy
showed that wild-type synaptotagmin is mainly present in
numerous vesicular structures likely to represent secretory
granules (Fig. 3C,D). A similar staining pattern was observed
for non-acylated tagmin indicating that palmitoylation is not
essential for transport to secretory organelles (Fig. 3E,F).
In summary, we have shown that processing of non-acylat-
ed tagmin (and probably also intracellular transport through
the Golgi complex) is retarded in CV-1 cells, but the non-
acylated protein is nevertheless targeted to the plasma mem-
brane and secretory organelles in PC-12 and RBL cells. One
possible explanation might be that there are di¡erences in
intracellular transport of non-acylated tagmin in cells without
(CV-1) and with (PC-12 and RBL cells) the protein machinery
for regulated secretion. Numerous interactions of synaptotag-
min with neurone-speci¢c proteins have been described and it
is possible that they compensate for the lack of the cysteine
residues and/or palmitoylation. Alternatively, intracellular
transport of non-acylated tagmin through the Golgi complex
might also be retarded in PC-12 and RBL cells, but is not
obvious when analysing the total pool of tagmin in £uores-
cence studies.
Similar to published results [17] we observed that expression
of synaptotagmin in PC-12 promotes neurite outgrowth.
However, a di¡erence between palmitoylated and non-acylat-
ed tagmin was not detectable (data not shown).
3.5. The majority of fatty acids are stably attached to
synaptotagmin
Protein palmitoylation is thought to be a reversible process
with cycles of palmitoylation and depalmitoylation. Depalmi-
toylation of proteins involved in signal transduction is almost
quantitative and half-times for the fatty acid turn-over as fast
as 15 min have been described [18]. In contrast, for other
proteins, for example viral glycoproteins, no cleavage of fatty
acids was detectable [14]. To analyse whether the fatty acids
bound to synaptotagmin and to another synaptosomal protein
(SNAP-25) turn-over rapidly, a pulse-chase experiment with
[3H]palmitate using PC-12 cells was performed. Although
there is some variation in the intensity of the bands, a signi¢-
cant and continuous reduction of [3H]palmitate labelling of
both proteins is not detectable during the chase (see Fig. 4A^
C). This indicates that the majority of fatty acids bound to
synaptotagmin and SNAP-25 are stably attached.
Palmitoylation of a protein in the absence of protein syn-
thesis is usually taken as an indication for reacylation of a
previously deacylated protein [11]. To analyse whether palmi-
toylation of tagmin requires ongoing protein synthesis, PC-12
cells were treated with cycloheximide at di¡erent time points
prior to labelling with [3H]palmitate. The intensity of
[3H]palmitoylation of tagmin continuously decreases with
the duration of the cycloheximide preincubation. After 20
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min of preincubation almost no [3H]palmitate labelling is
detectable (see Fig. 4D). The [3H]palmitate-labelled bands
detectable at earlier time points most likely represent synap-
totagmin molecules synthesised immediately before the
cycloheximide block and passing the intracellular site of pal-
mitoylation during the labelling period. Thus, signi¢cant turn-
over of the fatty acids of synaptotagmin does not occur in PC-
12 cells.
These results are surprising, because we and others have
found that synaptosomes and even synaptic vesicles can acy-
late endogenous tagmin [7,19]. However, it is feasible that
only some of the fatty acids are removed from each molecule
or that only a small subpopulation of all molecules present in
PC-12 cells is depalmitoylated. Furthermore, turn-over of
fatty acids might require activation of synaptotagmin, for ex-
ample during neurosecretion. Nevertheless, it is clear that
there is a di¡erence in depalmitoylation of neuronal SNARE
proteins and proteins involved in signal transduction. Only
the latter are signi¢cantly de- and reacylated, even in unstim-
ulated cells.
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